ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) Book value per share
ResMed Inc.'s book value per share at the end of fiscal 2026 was 45.3×, up 11.3% from 40.7× in fiscal 2025. Over the past ten years it has ranged from 11.3× (fiscal 2015) to 45.3× (fiscal 2026) — the current reading is the highest in ten years. ResMed Inc. ranks 6th of 55 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 45.3× | 11.25% |
| FY2025 | 40.7× | 22.95% |
| FY2024 | 33.1× | 17.57% |
| FY2023 | 28.1× | 22.30% |
| FY2022 | 23.0× | 15.86% |
| FY2021 | 19.9× | 14.79% |
| FY2020 | 17.3× | 19.48% |
| FY2019 | 14.5× | 0.40% |
| FY2018 | 14.4× | 4.00% |
| FY2017 | 13.9× | 14.75% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 45.3× | 1.31% |
| Mar 2026 | 44.7× | 3.06% |
| Dec 2025 | 43.3× | 3.50% |
| Sep 2025 | 41.9× | 2.95% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BDX Becton, Dickinson and Company compare | 88.9× |
| RMD ResMed Inc. | 45.3× |
| ALC Alcon compare | 44.4× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| RGEN Repligen Corporation compare | 37.4× |
| SOLV Solventum Corporation compare | 27.8× |
| MDLN Medline Inc. compare | 22.3× |
| BAX Baxter International Inc. compare | 12.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement